TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

Key Facts

Class Period: August 3, 2022 – November 2, 2022 Lead Plaintiff Deadline: November 7, 2023 If you wish to serve as lead plaintiff of the Tandem lawsuit, you can submit your contact information at www.glancylaw.com/cases/Tandem-Diabetes-Care-Inc/.
You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.